Ethyl 1-[(4-methoxyphenyl)methyl]-5-[3-[4-(trifluoromethoxy)phenyl]cyclopentyl]oxytriazole-4-carboxylate
C25H26F3N3O5 — CID 155422689
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 1-[(4-methoxyphenyl)methyl]-5-[3-[4-(trifluoromethoxy)phenyl]cyclopentyl]oxytriazole-4-carboxylate
Ethyl 1-[(4-methoxyphenyl)methyl]-5-[3-[4-(trifluoromethoxy)phenyl]cyclopentyl]oxytriazole-4-carboxylate (PubChem CID 155422689) has the molecular formula C25H26F3N3O5 and a molecular weight of 505.49 g/mol. Its IUPAC name is ethyl 1-[(4-methoxyphenyl)methyl]-5-[3-[4-(trifluoromethoxy)phenyl]cyclopentyl]oxytriazole-4-carboxylate.
Molecular Properties
| Compound Name | Ethyl 1-[(4-methoxyphenyl)methyl]-5-[3-[4-(trifluoromethoxy)phenyl]cyclopentyl]oxytriazole-4-carboxylate |
|---|---|
| PubChem CID | 155422689 |
| Molecular Formula | C25H26F3N3O5 |
| Molecular Weight | 505.49 g/mol |
| Exact Mass | 505.18 |
| IUPAC Name | ethyl 1-[(4-methoxyphenyl)methyl]-5-[3-[4-(trifluoromethoxy)phenyl]cyclopentyl]oxytriazole-4-carboxylate |
| SMILES | CCOC(=O)c1nnn(Cc2ccc(OC)cc2)c1OC1CCC(c2ccc(OC(F)(F)F)cc2)C1 |
| InChI | InChI=1S/C25H26F3N3O5/c1-3-34-24(32)22-23(31(30-29-22)15-16-4-9-19(33-2)10-5-16)35-21-13-8-18(14-21)17-6-11-20(12-7-17)36-25(26,27)28/h4-7,9-12,18,21H,3,8,13-15H2,1-2H3 |
| InChIKey | NHMHLUUPIMVYKM-UHFFFAOYSA-N |
| XLogP | 5.13 |
| TPSA | 84.70 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 505.49 |
| LogP ≤ 5 | 5.13 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155422689 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.